EMERGENT BIOSOLUTIONS INC. Net Income (Loss) Attributable to Noncontrolling Interest
EMERGENT BIOSOLUTIONS INC. (EBS) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-29.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2016-02-29
- EMERGENT BIOSOLUTIONS INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2014-12-31 was $0.00.
- EMERGENT BIOSOLUTIONS INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2014-09-30 was $0.00.
- EMERGENT BIOSOLUTIONS INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2014-06-30 was $0.00.
- EMERGENT BIOSOLUTIONS INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2014-03-31 was $0.00.
- EMERGENT BIOSOLUTIONS INC. net income (loss) attributable to noncontrolling interest for fiscal 2015 was $0.00.
- EMERGENT BIOSOLUTIONS INC. net income (loss) attributable to noncontrolling interest for fiscal 2014 was $0.00.
- EMERGENT BIOSOLUTIONS INC. net income (loss) attributable to noncontrolling interest for fiscal 2013 was -$876.00K.
- EMERGENT BIOSOLUTIONS INC. net income (loss) attributable to noncontrolling interest for fiscal 2012 was -$5.38M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $0.00 derived: sum of 3 quarters · filed 2016-02-29 | $0.00 10-K · filed 2016-02-29 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | -$5.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | -$5.00K derived: sum of 3 quarters · filed 2016-02-29 | -$5.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | -$5.00K derived: sum of 2 quarters · filed 2016-02-29 | -$5.00K derived: sum of 3 quarters · filed 2016-02-29 | -$133.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$5.00K derived: sum of 2 quarters · filed 2016-02-29 | -$133.00K derived: sum of 3 quarters · filed 2016-02-29 | -$876.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 | -$128.00K derived: sum of 2 quarters · filed 2014-11-10 | -$871.00K 10-Q · filed 2014-11-10 | -$1.98M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | -$128.00K 10-Q · filed 2014-08-08 | -$871.00K 10-Q · filed 2014-08-08 | -$1.98M derived: sum of 3 quarters · filed 2015-03-09 | -$2.97M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | -$743.00K 10-Q · filed 2014-05-12 | -$1.85M derived: sum of 2 quarters · filed 2015-03-09 | -$2.85M derived: sum of 3 quarters · filed 2015-03-09 | -$4.93M derived: sum of 4 quarters · filed 2015-03-09 |
| 2012-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | -$2.10M derived: sum of 2 quarters · filed 2015-03-09 | -$4.19M derived: sum of 3 quarters · filed 2015-03-09 | -$5.38M 10-K · filed 2015-03-09 |
| 2012-09-30 | -$997.00K 10-Q · filed 2013-11-08 | -$3.08M derived: sum of 2 quarters · filed 2013-11-08 | -$4.28M 10-Q · filed 2013-11-08 | -$6.03M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | -$2.09M 10-Q · filed 2013-08-06 | -$3.28M 10-Q · filed 2013-08-06 | -$5.04M derived: sum of 3 quarters · filed 2014-03-10 | -$6.72M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | -$1.19M 10-Q · filed 2013-05-03 | -$2.95M derived: sum of 2 quarters · filed 2014-03-10 | -$4.64M derived: sum of 3 quarters · filed 2014-03-10 | -$6.32M derived: sum of 4 quarters · filed 2014-03-10 |
| 2011-12-31 | -$1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | -$3.44M derived: sum of 2 quarters · filed 2014-03-10 | -$5.13M derived: sum of 3 quarters · filed 2014-03-10 | -$6.91M 10-K · filed 2014-03-10 |
| 2011-09-30 | -$1.69M 10-Q · filed 2012-11-01 | -$3.37M derived: sum of 2 quarters · filed 2012-11-01 | -$5.15M 10-Q · filed 2012-11-01 | -$7.51M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | -$1.69M 10-Q · filed 2012-08-03 | -$3.46M 10-Q · filed 2012-08-03 | -$5.82M derived: sum of 3 quarters · filed 2013-03-08 | -$7.00M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | -$1.78M 10-Q · filed 2012-05-04 | -$4.13M derived: sum of 2 quarters · filed 2013-03-08 | -$5.31M derived: sum of 3 quarters · filed 2013-03-08 | -$5.68M derived: sum of 4 quarters · filed 2013-03-08 |
| 2010-12-31 | -$2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | -$3.54M derived: sum of 2 quarters · filed 2013-03-08 | -$3.91M derived: sum of 3 quarters · filed 2013-03-08 | -$4.51M 10-K · filed 2013-03-08 |
| 2010-09-30 | -$1.18M 10-Q · filed 2011-11-04 | -$1.55M derived: sum of 2 quarters · filed 2011-11-04 | -$2.15M 10-Q · filed 2011-11-04 | |
| 2010-06-30 | -$374.00K 10-Q · filed 2011-08-05 | -$979.00K 10-Q · filed 2011-08-05 | ||
| 2009-12-31 | -$4.60M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |